What PSYCHEMEDICS CORP's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Powell Anderson Capital Partners Llc | 10% owner | Dec 17 | Open-market buy · P | +9,850 | $1.87 | +$18.4K | 614,406 |
| Powell Anderson Capital Partners Llc | 10% owner | Dec 17 | Open-market buy · P | +9,850 | $1.87 | +$18.4K | 369,850 |
| Powell Anderson Capital Partners Llc | 10% owner | Dec 16 | Open-market buy · P | +30,000 | $1.97 | +$59.1K | 604,556 |
| Powell Anderson Capital Partners Llc | 10% owner | Dec 16 | Open-market buy · P | +30,000 | $1.97 | +$59.1K | 360,000 |
| Powell Anderson Capital Partners Llc | 10% owner | Dec 13 | Open-market buy · P | +80,000 | $1.88 | +$150K | 574,556 |
| Powell Anderson Capital Partners Llc | 10% owner | Dec 12 | Open-market buy · P | +75,000 | $2.67 | +$200K | 494,556 |
| Powell Anderson Capital Partners Llc | 10% owner | Dec 11 | Open-market buy · P | +4,518 | $2.71 | +$12.2K | 419,556 |
| Kamin Peter H | Director | Dec 10 | Open-market sale · S | −320,708 | $2.35 | −$754K | 1,499,710 |
| Powell Anderson Capital Partners Llc | 10% owner | Dec 10 | Open-market buy · P | +7,473 | $2.59 | +$19.4K | 415,038 |
| Kamin Peter H | Director | Dec 03 | Open-market buy · P | +1,409,712 | $2.35 | +$3.31M | 1,820,418 |
| Kamin Peter H | Director | Aug 17 | Grant / award · A | +14,000 | — | — | 237,031 |
| Davis Robyn C | Director | Aug 17 | Grant / award · A | +14,000 | — | — | 39,000 |
| Reynolds Andrew | Director | Aug 17 | Grant / award · A | +14,000 | — | — | 28,000 |
| Doucot Charles M | Executive Vice President | Aug 17 | Open-market sale · S | −12,700 | $4.66 | −$59.2K | 23,250 |
| Weisenhoff Michael | Insider | Aug 17 | Grant / award · A | +4,000 | — | — | 4,000 |
| Nevin Darius G | Director | Aug 17 | Grant / award · A | +14,000 | — | — | 23,000 |
| Kubacki Raymond C Jr | Chairman, CEO & President | May 22 | Withheld — tax / exercise cost · F | −1,500 | $4.93 | −$7.4K | 246,737 |
| Doucot Charles M | Executive Vice President | May 22 | Withheld — tax / exercise cost · F | −825 | $4.93 | −$4.07K | 35,950 |
| Schaffer Michael I | VP of Laboratory Operations | May 22 | Withheld — tax / exercise cost · F | −375 | $4.93 | −$1.85K | 36,489 |
| Kubacki Raymond C Jr | Chairman, CEO & President | May 15 | Withheld — tax / exercise cost · F | −1,725 | $4.87 | −$8.4K | 248,237 |
Loading...
